OUR PUBLICATIONS
2022
African-specific polymorphisms in Plasmodium falciparum serine repeat antigen 5 in Uganda and Burkina Faso clinical samples do not interfere with antibody response to BK-SE36 vaccination
Arisue N, Palacpac NMQ, Ntege EH, Yeka A, Balikagala B, Kanoi BN, Bougouma EC, Tiono AB, Nebie I, Diarra A, Houard S, D'Alessio F, Leroy O, Sirima SB, Egwang TG, Horii T.
Front Cell Infect Microbiol. 2022 Dec 16;12:1058081.
2022
Impact of exposure to malaria and nutritional status on responses to the experimental malaria vaccine ChAd63 MVA ME-TRAP in 5-17 month-old children in Burkina Faso
Morter R, Tiono AB, Nébié I, Hague O, Ouedraogo A, Diarra A, Viebig NK, Hill AVS, Ewer KJ, Sirima SB.
Front Immunol. 2022 Dec 2;13:1058227
2022
A novel asexual blood-stage malaria vaccine candidate: PfRipr5 formulated with human-use adjuvants induces potent growth inhibitory antibodies
Takashima E, Nagaoka H, Correia R, Alves PM, Roldão A, Christensen D, Guderian JA, Fukushima A, Viebig NK, Depraetere H, Tsuboi T.
Front. Immunol., 2022 Oct 27; 13:1002430
2022
Vaccination rates in Europe are not associated with online media intensity
Luís C, Di Marzo VR, Kaur M, Argyropoulos CD, Devane D, Stewart FA, Antoniou G, Hendrickx G, Askling HH, Hellemans M, Cohen M, Spivak O, Van Damme P, Jane Cox R, Vene S, Sibia S, Pana ZD, Olesen OF, on behalf of VACCELERATE Consortium
Journal of Science Communication 21(05)(2022)A05
2022
Safety and immunogenicity of BK-SE36 in a blinded, randomized, controlled, age de-escalating phase Ib clinical trial in Burkinabe children
Bougouma EC, Palacpac NMQ, Tiono AB, Nebie I, Ouédraogo A, Houard S, Yagi M, Coulibaly SA, Diarra A, Tougan T, Ouedraogo AZ, Soulama I, Arisue N, Yaro JB, D’Alessio F, Leroy O, Cousens S, Horii T, Sirima SB
Front Immunol. 2022 Aug 31;13:978591
2022
VACCELERATE Volunteer Registry: A European study participant database to facilitate clinical trial enrolment
Salmanton-García J, Stewart FA, Heringer S, Koniordou M, Álvarez-Barco E, Argyropoulos CD, Themistocleous SC, Valle-Simón P, Spivak O, Součková L, Merakou C, Amélia Mendonça M, Joanna Davis R, Maria Azzini A, Askling HH, Vene S, Van Damme P, Steinbach A, Shiamakkides G, Seidel D, Olesen OF, Noula E, Macken A, Luís C, Leckler J, Launay O, Isitt C, Hellemans M, Frías-Iniesta J, Di Marzo R, Carcas AJ, Boustras G, Borobia AM, Barta I, Albus K, Akova M, Ochando J, Cohen-Kandli M, Jane Cox R, Husa P, Jancoriene L, Mallon P, Marques L, Mellinghoff SC, Nauclér P, Tacconelli E, Tóth K, Zaoutis TE, Zeitlinger M, Cornely OA, Pana ZD
Vaccine. 2022 Jul 29;40(31):4090-4097
2022
Asexual Blood-Stage Malaria Vaccine Candidate PfRipr5: Enhanced Production in Insect Cells
Correia R, Fernandes B, Castro R, Nagaoka H, Takashima E, Tsuboi T, Fukushima A, Viebig NK, Depraetere H, Alves PM, Roldão A.
Front Bioeng Biotechnol. 2022 Jun 30;10:908509
2022
Funders’ Perspectives on Supporting Implementation Research in Low- and Middle-Income Countries
Cardoso-Weinberg A, Alley C, Kupfer LE, Aslanyan G, Makanga M, Zicker F, Olesen OF
Glob Health Sci Pract. 2022;10(2):e2100497.
2022
A gaps-and-needs analysis of vaccine R&D in Europe: Recommendations to improve the research infrastructure
Jungbluth S, Depraetere H, Slezak M, Christensen D, Stockhofe N, Beloeil LA
Biologicals. 2022 Feb 26:S1045-1056(22)00017-3.
2021
Controlled Human Infection Studies: Proposals for guidance on how to design, develop and produce a challenge strain
Bekeredjian-Ding I, Trouvin JH, Depraetere H, La C, Suvarnapunya AE, Bell A, Mann A, Meij P, Bethony JM, Schellhaas L, Nazziwa WB, Karikari-Boateng E, Prachumsri JS, Salmikangas P, Smith D, Stjärnkvist P, Van Molle W, Baay M, Neels P
Biologicals. 2021 Nov;74:16-23.